Grail News and Activities
Presence
Grail develops blood-based cancer screening and early detection services. Its products help healthcare providers, health systems, and employers identify cancer signals in people without symptoms.
Grail products and services overview:
- Cancer screening tests
- Blood diagnostic tests
- Early detection services
- Laboratory testing services
Revenue: ~$130 million
Employees: 900
Headquarters: Menlo Park, United States (USA)
Illumina is one of the...
Illumina is a company listed under the stock ticker ILMN (US).
Illumina has 3 subsidiaries including Grail, Illumina Ventures and PacBio.
They are in:
- Biotechnology50%
- Medical Equipment25%
- Other25%
Acquisition, funding and merger involving Illumina.
- Illumina has acquired SomaLogic (posted on January 30 2026).
- Illumina has announced the acquisition of SomaLogic (posted on June 23 2025).
Executives
View the org chart displaying its 20 main executives
Most searched biographies at Grail
Popular executive movements at Grail
- Bob Ragusa, Chief Executive Officer and Director, will leave the company on Jun. 1, 2026 (posted on March 13 2026).
- Joshua Ofman who is President, will be promoted to Chief Executive Officer on Jun. 1, 2026 (posted on March 13 2026).
Popular executive movements at Illumina
- David King has joined the company as Director (posted on April 2 2026).
- Gary Guthart, Director, is retiring (posted on April 2 2026).
- Robert Epstein, Director, is retiring (posted on April 2 2026).
Click here to view some more movements at Illumina
Create your alert
to follow the executive moves at Grail.
Biotechnology
Illumina has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
- NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
- Rallybio and Avenzo Therapeutics have announced they will merge (posted on June 1 2026)..
Popular contacts in Biotechnology
News
Press releases by Grail
- GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - GRAIL
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GRAIL
- GRAIL Reports First Quarter 2026 Financial Results - GRAIL
- GRAIL to Present at the BofA Securities 2026 Health Care Conference - GRAIL
- GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting - GRAIL
- GRAIL to Announce First Quarter 2026 Financial Results - GRAIL
- GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide - GRAIL
- GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor - GRAIL
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GRAIL
- GRAIL to Present at the TD Cowen 46th Annual Health Care Conference - GRAIL
- View more press releases Close
Social media about Grail
- Grail on Wikipedia, Google News & Yahoo Finance
- Grail on LinkedIn, X (Twitter) & YouTube
